Drugs / Sage extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02032862 | Dec 2013 → Jul 2015 | — | A. Vogel AG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sage extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02032862 ↗ |
| Known as | Sage tablets | “Sage tablets ( 3400 mg extract from fresh sage leaves, DER 1:17)” NCT02032862 ↗ |